CA978479A - Composition for the dissolution of renal calculi and process for the preparation thereof - Google Patents

Composition for the dissolution of renal calculi and process for the preparation thereof

Info

Publication number
CA978479A
CA978479A CA155,789A CA155789A CA978479A CA 978479 A CA978479 A CA 978479A CA 155789 A CA155789 A CA 155789A CA 978479 A CA978479 A CA 978479A
Authority
CA
Canada
Prior art keywords
dissolution
preparation
composition
renal calculi
calculi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA155,789A
Other languages
English (en)
Other versions
CA155789S (en
Inventor
Gyula Gal
Dezso Frang
Jozsef Nemes
Mihaly Berenyi
Miklos Marso
Rudolf Szebeni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Application granted granted Critical
Publication of CA978479A publication Critical patent/CA978479A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA155,789A 1971-11-08 1972-11-07 Composition for the dissolution of renal calculi and process for the preparation thereof Expired CA978479A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI1185A HU165181B (el) 1971-11-08 1971-11-08

Publications (1)

Publication Number Publication Date
CA978479A true CA978479A (en) 1975-11-25

Family

ID=10994422

Family Applications (1)

Application Number Title Priority Date Filing Date
CA155,789A Expired CA978479A (en) 1971-11-08 1972-11-07 Composition for the dissolution of renal calculi and process for the preparation thereof

Country Status (9)

Country Link
AT (1) AT332531B (el)
CA (1) CA978479A (el)
CS (1) CS217603B1 (el)
DD (1) DD100631A1 (el)
DE (1) DE2252665A1 (el)
GB (1) GB1403900A (el)
HU (1) HU165181B (el)
IL (1) IL40685A (el)
SU (1) SU1009467A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2826642C2 (de) 1978-06-19 1987-04-23 Dr. Madaus & Co, 5000 Köln Orales Urolithiasismittel
DE3046580A1 (de) * 1980-12-11 1982-07-01 Leskovar, Peter, Dr.-Ing., 8000 München Harnsteinaufloesende mittel
DE3728814A1 (de) * 1987-08-28 1989-03-30 Lentia Gmbh Loesung zur anwendung als spuelfluessigkeit in der zerstoerung von koerperfremden ablagerungen in menschlichen und tierischen geweben oder koerperhohlraeumen
JP2545479B2 (ja) * 1989-02-07 1996-10-16 ミッション ファーマカル カンパニー，インコーポレーテッド 医薬組成物
CA1326040C (en) * 1989-11-16 1994-01-11 Neill B. Walsdorf Magnesium-potassium citrate
DE4409949C2 (de) * 1994-03-23 1996-11-21 Madaus Ag Verwendung von Calcium-Alkalicitraten zur Prophylaxe und Behandlung degenerativer Erkrankungen des Knochengerüstes
DE10028167B4 (de) * 2000-06-09 2004-02-19 Storch, Rüdiger, Dr. Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen
WO2009143021A1 (en) * 2008-05-22 2009-11-26 Bristol-Myers Squibb Company Method for treating and preventing kidney stones employing an sglt2 inhibitor and composition containing same
FR2967576B1 (fr) * 2010-11-18 2013-07-12 Advicenne Pharma Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament
FR2967578B1 (fr) 2010-11-18 2012-12-28 Advicenne Pharma Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie
US9278112B2 (en) * 2013-03-15 2016-03-08 New York University Citrate containing beverage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328304A (en) * 1964-07-31 1967-06-27 Guardian Chemical Corp Chelating agents and methods for their manufacture
FR2019261A1 (en) * 1969-03-19 1970-07-03 Melon Jean Marie Treatment of oxalic lithiase with succinic - acid and its derivs

Also Published As

Publication number Publication date
IL40685A0 (en) 1972-12-29
DE2252665A1 (de) 1973-05-10
GB1403900A (en) 1975-08-28
AT332531B (de) 1976-10-11
IL40685A (en) 1976-08-31
DD100631A1 (el) 1973-10-05
SU1009467A1 (ru) 1983-04-07
CS217603B1 (en) 1983-01-28
HU165181B (el) 1974-07-27
ATA925372A (de) 1976-01-15
DE2252665C2 (el) 1987-09-10

Similar Documents

Publication Publication Date Title
CA980353A (en) Substituted phenylalkanol derivatives and process for the preparation thereof
CA978479A (en) Composition for the dissolution of renal calculi and process for the preparation thereof
CA979437A (en) 15-oxoprostanoic acid derivatives and process for the preparation thereof
CA1003631A (en) Antiozonant-antioxidant composition and process for preparation thereof
CA996026A (en) Hormone and process for the preparation thereof
CA998495A (en) Modified polyisoprene and process for the preparation thereof
CA959843A (en) Process for the preparation of 1-phenyl-4-amino-cyclohex-2-ene-1-carboxylic-acid-esters and the salts thereof
AU458800B2 (en) New pyridylpiperazines and process for their preparation
CA944692A (en) Pharmaceutical composition and process for the preparation thereof
AU4615372A (en) Fungicidal composition and process
CA989874A (en) Process for the preparation of pentafluorethyl iodide and heptafluorisopropyl iodide
AU4694172A (en) Substituted isoquinolones and process forthe preparation thereof
CA998049A (en) Pyrazinoindole derivatives and process for the preparation thereof
AU5019272A (en) Composition and process
CA1006522A (en) N-acyl-(piperazinoalkyl)-pyrazoles and process for the preparation thereof
AU481489B2 (en) Composition for the dissolution of renal calculi and process for the preparation thereof
CA966777A (en) Delayed action antiseptic composition and the process for its preparation
CA983958A (en) Process for the preparation of imines
AU4815172A (en) Composition for the dissolution of renal calculi and process for the preparation thereof
CA960213A (en) Process for the preparation of 3-azolylpropynes and compounds thereby produced
CA869971A (en) Dissolution process and composition
CA996941A (en) Process for the preparation of arylalkyl-pyrryl aminoethanols and new intermediate compounds for performing the same
CA992952A (en) Process for the preparation of bufalin and related compounds
AU472732B2 (en) 17-esters of 60-90(difluoro-21-desoxyprednisolone and process for the preparation thereof
AU460636B2 (en) Process for the preparation of diaminodiaryl-methanes and polyaminopolyarylmethanes